Precision oncology startup Abdera launches with seed round

Vancouver-based precision oncology company Abdera Therapeutics has launched with a seed-stage financing of C$8 million.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this